StimOxyGen

To add a bio or update company history, please click update information.

News from StimOxyGen

StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy

11 Mar 2025

StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy

StimOxyGen develops oxygen delivery therapies designed to improve tumour response to radiotherapy and immunotherapy by addressing hypoxia in solid cancers, initially focusing on pancreatic cancer.

StimOxyGen

Life Sciences
Coleraine, United Kingdom
£1.5m
stimoxygen.com
Update Information

More venture news

Pharosyn
2 Sept 2026
Pharosyn secures £2.2m in funding led by Moonfire to improve commercial decision-making inside pharma companies
EquityLife Sciences
CN Bio
12 Aug 2026
CN Bio secures a £180k Innovate UK grant to develop organ-on-a-chip system for drug behaviour predictions
GrantLife Sciences
Mironid
5 Aug 2026
Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases
Series BLife Sciences

StimOxyGen

News from StimOxyGen

StimOxyGen raises £1.5m seed led by DSW Ventures to advance oxygen-based cancer therapy

More venture news

Pharosyn secures £2.2m in funding led by Moonfire to improve commercial decision-making inside pharma companies

CN Bio secures a £180k Innovate UK grant to develop organ-on-a-chip system for drug behaviour predictions

Mironid raises a £34m Series B including £8.4m from Scottish National Investment Bank to advance small molecule treatments for kidney diseases